Investigating Citric Acid Cycle Perturbations in Complex I Deficient Mitochondrial Encephalopathy
研究复合物 I 缺陷型线粒体脑病中柠檬酸循环的扰动
基本信息
- 批准号:10609528
- 负责人:
- 金额:$ 37.25万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-05-01 至 2026-04-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAffectAnti-Inflammatory AgentsAtaxiaBasal GangliaBiochemicalBioenergeticsBrainBrain StemBypassCellsChemicalsCitric Acid CycleClinicalComplexCysteineDataDefectDevelopmental Delay DisordersDiseaseEncephalopathiesEngineeringEpigenetic ProcessEstersExhibitsFumaratesFunctional disorderGenerationsGenesGeneticGliosisGuanosine TriphosphateHistone H3HumanImpairmentInfiltrationInflammationInflammatoryKetoglutarate Dehydrogenase ComplexKnock-outKnockout MiceLactic AcidosisLeigh DiseaseLesionLifeLinkLive BirthLysineMalate DehydrogenaseMediatingMetabolic acidosisMetabolismMicrogliaMitochondriaMitochondrial DiseasesMitochondrial complex I deficiencyModelingModificationMutationNeurogliaNeuronsOxidative PhosphorylationPathologicPathologyPeptidesPermeabilityPhagocytesPhenotypePhosphorylationPost-Translational Protein ProcessingProductionProteinsReactionReportingResolutionRespiratory ChainRoleSeizuresSeveritiesSiteTherapeuticalpha ketoglutaratedemethylationdesigneffective therapyhistone demethylasehistone methylationindividualized medicineinsightmouse modelneuroinflammationneuron lossneuropathologynovelolfactory bulbpreventrespiratorysuccinyl-coenzyme Atargeted treatmenttranscription regulatory network
项目摘要
ABSTRACT
Mitochondrial diseases are respiratory chain disorders in which the mitochondria are no longer operating
efficiently to produce ATP, usually due to a problem with one or more components of the oxidative
phosphorylation machinery. Mitochondrial diseases manifesting as encephalopathies occur at a rate of 1 in 5000
live births and are often fatal in the first few years of life. The genetic cause and clinical course of these
encephalopathies, e.g., Complex I deficient Leigh Syndrome, are well-described. The effective treatment of these
diseases is limited by our lack of mechanistic understanding of pathomechanisms that drive neuronal decline,
beyond the known Complex-I bioenergetic deficit.
We have previously described the reaction of the citric acid cycle metabolite fumarate with protein cysteine
residues to generate an irreversible modification, 2-succinocysteine (2SC), also known as protein succination.
Fumarate and protein succination increase in the Ndufs4 knockout mouse model of mitochondrial Complex I
deficiency. We demonstrate that the succination of a component of the α-ketoglutarate dehydrogenase (α-
KGDH) complex impairs the enzymatic activity of this complex. This results in decreased succinyl CoA production,
and impaired substrate level phosphorylation to produce much needed GTP/ATP. We hypothesize that metabolic
acidosis derived from the Complex I loss redirects α-KG toward 2-hydroxyglutarate production. We predict that
this influences the epigenetic landscape in the affected neurons.
The citric acid cycle of other non-neuronal cells are also impacted in the Ndufs4 knockout mouse. We show
preliminary data to demonstrate an impaired ability to produce itaconate, an important anti-inflammatory
metabolite. This is significant given the accumulation of microglia in the center of neuropathological lesions. Our
novel hypotheses link specific citric acid cycle perturbations to the chemical modifications of proteins that may
accelerate the biochemical damage within the regions most affected by pathology. To address these specific
pathomechanisms we outline targeted therapeutic approaches that should reduce the drivers of neuropathology.
摘要
线粒体疾病是呼吸链疾病,线粒体不再在其中运行
有效地产生三磷酸腺苷,通常是由于氧化的一个或多个成分出现问题
磷酸化机器。表现为脑病的线粒体疾病的发生率为1/5000
活产,通常在生命的头几年是致命的。这些疾病的遗传原因和临床过程
脑病,如复杂I缺乏症,是很好的描述。对这些疾病的有效治疗
疾病受到我们对驱动神经元衰退的病理机制缺乏机械性理解的限制,
超越了已知的复合体-I生物能量赤字。
我们之前已经描述了柠檬酸循环代谢产物富马酸与蛋白质半胱氨酸的反应。
残基产生不可逆的修饰,2-琥珀酸半胱氨酸(2SC),也称为蛋白质琥珀酸化。
线粒体复合体I的Ndufs4基因敲除小鼠模型中富马酸和蛋白质琥珀酸化增加
缺乏症。我们证明了α-酮戊二酸脱氢酶(α-)的一个成分的琥珀酸化。
KGDH)复合体会削弱该复合体的酶活性。这导致琥珀酰辅酶A产生减少,
并损害底物水平的磷酸化,以产生急需的GTP/ATP。我们假设新陈代谢
复合体I丢失引起的酸中毒使α-KG重定向生成2-羟基戊二酸。我们预测
这会影响受影响神经元的表观遗传格局。
在Ndufs4基因敲除小鼠中,其他非神经细胞的柠檬酸循环也受到影响。我们展示了
初步数据显示产生衣康酸的能力受损,衣康酸是一种重要的抗炎药物
代谢物。考虑到小胶质细胞聚集在神经病理损伤的中心,这一点很明显。我们的
新的假说将特定的柠檬酸循环扰动与蛋白质的化学修饰联系起来,这可能
在受病理影响最严重的区域加速生化破坏。要解决这些具体问题
病理机制我们概述了针对性的治疗方法,应该减少神经病理的驱动因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Norma Frizzell其他文献
Norma Frizzell的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Norma Frizzell', 18)}}的其他基金
Developing Tools to Understand an Alternative Fate of Urate in Neurodegenerative Diseases
开发工具来了解尿酸盐在神经退行性疾病中的替代命运
- 批准号:
10668103 - 财政年份:2023
- 资助金额:
$ 37.25万 - 项目类别:
Anaplerotic Therapy for Mitochondrial Complex I Deficiency
线粒体复合物 I 缺乏症的回补疗法
- 批准号:
10118501 - 财政年份:2020
- 资助金额:
$ 37.25万 - 项目类别:
Protein Succination as a Mediator of Neuropathology in Mitochondrial Disease
蛋白琥珀化作为线粒体疾病神经病理学的中介
- 批准号:
8942973 - 财政年份:2015
- 资助金额:
$ 37.25万 - 项目类别:
Protein Succination as a Mediator of Neuropathology in Mitochondrial Disease
蛋白琥珀化作为线粒体疾病神经病理学的中介
- 批准号:
9268095 - 财政年份:2015
- 资助金额:
$ 37.25万 - 项目类别:
Protein Succination as a Mediator of Neuropathology in Mitochondrial Disease
蛋白琥珀化作为线粒体疾病神经病理学的中介
- 批准号:
9122509 - 财政年份:2015
- 资助金额:
$ 37.25万 - 项目类别:
Protein Succination: a Mechanistic Mediator of Adipocyte Dysfunction in Diabetes
蛋白质琥珀化:糖尿病脂肪细胞功能障碍的机制介质
- 批准号:
9117530 - 财政年份:2015
- 资助金额:
$ 37.25万 - 项目类别:
Detection of S-(2-succino)cysteine (2SC) as a Biomarker of Mitochondrial Disease
检测 S-(2-琥珀酰)半胱氨酸 (2SC) 作为线粒体疾病的生物标志物
- 批准号:
8571892 - 财政年份:2013
- 资助金额:
$ 37.25万 - 项目类别:
Detection of S-(2-succino)cysteine (2SC) as a Biomarker of Mitochondrial Disease
检测 S-(2-琥珀酰)半胱氨酸 (2SC) 作为线粒体疾病的生物标志物
- 批准号:
8725715 - 财政年份:2013
- 资助金额:
$ 37.25万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 37.25万 - 项目类别:
Research Grant